FDA: Updated OxyContin Not Successful In Decreasing Overdoses, Deaths

The video discusses the ineffectiveness of modified OxyContin pills in reducing drug misuse and overdoses, as reported by an FDA panel. Despite being harder to crush, the pills have not decreased overall misuse. Purdue Pharma's evidence of abuse reduction is criticized, and the shift to heroin use is noted. Heroin overdoses increased after the new OxyContin release. Purdue, facing lawsuits, filed for bankruptcy and plans to work with the FDA. The company targeted states with weak prescription regulations.

What trends have been observed in heroin overdoses following the release of the new OxyContin?

What actions is Purdue Pharma planning to take in response to the FDA's review of studies?